Produktbild
Arthur J. (Hrsg.) McCullough

Fatty Liver Disease

NASH and Related Disorders

Ebook (PDF Format)

Fatty liver disease, especially non-alcoholic steatohepatitis (NASH), is emerging as the most common form of liver disease - affecting at least 5% of the population of western countries with increasing incidence in developing economies in other continents (particularly Asia, South America and South Africa). NASH is the form of fatty liver disorder which can result in cirrhosis, particularly in those with diabetes or who are overweight, yet it is still not widely recognised despite its already high and increasing prevalence worldwide. This book explains what NASH is, why it happens, who gets it, how it can result in cirrhosis, when to think a… Mehr

CHF 172.00

Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)

Versandfertig innerhalb 1-3 Werktagen
Versandkostenfrei

Produktdetails


Weitere Autoren: Hall, Pauline de la M. (Hrsg.) / George, Jacob (Hrsg.) / Farrell, Geoffrey C. (Hrsg.)
  • ISBN: 978-1-4051-4100-0
  • EAN: 9781405141000
  • Produktnummer: 13890670
  • Verlag: Wiley-Blackwell
  • Sprache: Englisch
  • Erscheinungsjahr: 2008
  • Seitenangabe: 336 S.
  • Plattform: PDF
  • Masse: 3'174 KB

Über den Autor


Geoff Farrell, Professor of Hepatic Medicine, Director of Gastroenterology, The Canberra Hospital, AustraliaGeoffrey Farrell graduated MB BS from the University of Tasmania in 1970, and trained in gastroenterology and hepatology at the Royal Prince Alfred and Royal Brisbane Hospitals, the latter with Lawrie Powell with whom he completed an MD on hepatic drug metabolism. He was awarded an NHMRC CJ Martin Fellowship to conduct post-doctoral research in UCSF, and in 1980 returned to Sydney to establish a Liver Research Group at Westmead Hospital. He was promoted to a personal chair in 1993, then accepted the Storr Chair in Hepatic Medicine. He remained Director of the Storr Liver Unit until Jan 2006, when he accepted the position as Professor of Hepatic Medicine with ANU Medical School and Director of Gastroenterology and Hepatology at The Canberra Hospital. He has held many leadership roles in medical research, gastroenterology, editorial boards, and academic medicine, including Editor-in-Chief of Journal of Gastroenterology and Hepatology since November 2006.Geoff Farrell's research interests are in non-alcoholic steatohepatitis, viral hepatitis, drug-induced liver injury, and liver regeneration. He has published 3 books, including the first on non-alcoholic fatty liver disease, and written more than 180 scientific papers and 100 reviews/chapters and editorials in the fields of hepatology and biochemical pharmacology. His work is very highly cited, with an H-index of 50, more than 20 articles cited >100 times, average citation 32 per paper, and 15 articles being the subject of editorials in major medical journals. He is CIA on an NHMRC Program Grant to study the molecular and cellular basis of liver disease, and has recently held a Centre for Clinical Research Excellence Program grant to improve outcomes for patients with liver disease. Jacob George is the editor of Fatty Liver Disease: NASH and Related Disorders, published by Wiley. Pauline de la M. Hall is the editor of Fatty Liver Disease: NASH and Related Disorders, published by Wiley. Arthur McCullough, Department Chair of Gastroenterology and Hepatology, Cleveland Clinic, USAArthur McCullough, MD, is Department Chair of Gastroenterology and Hepatology and a Staff Physician in the Department of Pathobiology and Transplantation Center at Cleveland Clinic. He was appointed in 2006. He attended medical school at SUNY Health Science Center at University Hospital of Syracuse, N.Y. He completed his internship and residency at Cleveland Clinic and a fellowship at Mayo Clinic in Rochester, Minn.He is one of the most senior hepatologists in the United States and is the current President of the American Association for the Study of Liver Diseases. Other significant achievements are: Best Doctor's in America: Midwest Region annually from 1996-2008; Chair of the NIH-funded Clinical Research Network on Fatty Liver Disease (federal funding); NIH Grant on Omega 3 Fatty Acids in Diabetes (federal funding); New Novel Agents for Hepatitis C Patients who failed to respond to previous therapy (non-federal funding).

2 weitere Werke von Arthur J. (Hrsg.) McCullough:


Bewertungen


0 von 0 Bewertungen

Geben Sie eine Bewertung ab!

Teilen Sie Ihre Erfahrungen mit dem Produkt mit anderen Kunden.